Clinical Genomics Uppsala accelerates development of clinical long-read sequencing applications


Clinical Genomics Uppsala has recently recruited Ida Höijer to advance the development of clinical applications of long-read sequencing. Ida performed her PhD studies on long-read technologies, and has been invited to present her work at ESHG and at Harvard Medical School

Evaluation of clinical applications of long-read sequencing is one of the focus areas for Clinical Genomics Uppsala, and Ida’s experience in the field will be very valuable for the facility. Ongoing projects at Clinical Genomics Uppsala includes both whole-genome and targeted approaches of long-read sequencing in hematology and inherited diseases.

Ida will give the presentation “Long-read sequencing reveals heritable large structural variants induced by CRISPR-Cas9” in the plenary highlight session “What’s new?” at ESHG in June. She will also present at the Genome Engineering Seminar Series at Harvard Medical School on April 11. The work was recently published in Nature Communications

Ida has a background at the National Genomics Infrastructure (NGI) in Uppsala, and recently finalized her PhD studies in Ulf Gyllensten’s group at the Department of Immunology, Genetics and Pathology. She currently divides her time between Clinical Genomics Uppsala and NGI Uppsala.

Last modified: 2024-02-23